| The MYCN oncoprotein as a drug development target. | None |
| Dinucleotide repeat polymorphism at the human c-myc oncogene locus (MYC). | None |
| Immunolocalization of c-myc oncoprotein in mucinous and serous adenocarcinomas of the ovary. | None |
| The N-myc proto-oncogene: developmental expression and in vivo site-directed mutagenesis. | None |
| Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. | None |
| The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth. | None |
| Cell transformation by the v-myc oncogene abrogates c-Myc/Max-mediated suppression of a C/EBP beta-dependent lipocalin gene. | None |
| An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. | None |
| Expressions of vascular endothelial growth factor in cirrhotic tissues and their relations to proto-oncogene c-fos, c-myc. | None |
| ANXA2 is a Ca(2+)-dependent RNA-binding protein that interacts with the mRNA of the nuclear oncogene, c-myc | None |
| Mnt represses Myc target genes and Myc functions as an oncogene by relieving Mnt-mediated repression | None |
| Prognostic value of N-myc oncogene amplification and S-100 protein positivity in children with neuroblastic tumors. | None |
| A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. | None |
| Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation. | None |
| PINning down the c-Myc oncoprotein. | None |
| N-myc transcription molecule and oncoprotein. | None |
| Role of the c-myc proto-oncogene in the proliferation of hereditary gingival fibromatosis fibroblasts. | None |
| Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein. | None |
| C-Myc over-expression was significantly associated with high sVEGF and normal sFlt-1 level in DLBCL patients, suggesting a complex interrelationship between c-Myc oncogene expression and angiogenic regulators | None |
| Absence of p21WAF1 cooperates with c-myc in bypassing Ras-induced senescence and enhances oncogenic cooperation. | None |